VDR and breast carcinoma: The vitamin D receptor is a nuclear receptor present on over 80% of human breast cancers and mediates the action of 1,25-dihydroxy-vitamin D3, the biologically active form of vitamin D, that modulates differentiation, cell cycle and apoptosis of stromal and epithelial cells derived from mammary gland and breast cancers in vitro [56–60].